Arrowstreet Capital
BIVV

Arrowstreet Capital’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Arrowstreet Capital’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,112,134
Closed -$60M – 1468
2017
Q4 		$60M Sell
1,112,134
-397,500
-26% -$21.7M 0.14% 158
2017
Q3 		$86.2M Buy
1,509,634
+620,417
+70% +$36.3M 0.23% 108
2017
Q2 		$53.5M Buy
+889,217
New +$50.6M 0.16% 152

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Arrowstreet Capital's BIVV Position: Q1 2018 in Review

Arrowstreet Capital sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,112,134 shares — an estimated $60M sold.

Arrowstreet Capital first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $86.2M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Arrowstreet Capital reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Arrowstreet Capital sold 1,112,134 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $60M.
  • Arrowstreet Capital first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Arrowstreet Capital's Bioverativ Inc. Common Stock position peaked at $86.2M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.